Nocion Therapeutics is a private, F-Prime/Canaan-backed platform company addressing pain/itch across multiple therapeutic areas, starting with chronic cough.

And to shepherd that lead program into the clinic, Occam has recruited Chris Silber as the company’s Chief Medical Officer. Silber brings to Nocion a comprehensive and versatile background in clinical development, spanning early and late stage, with a long suit in neuro, CNS, and pain.

Most recently, Silber ran drug development for Sage Therapeutics, where he advanced multiple CNS programs through the clinic and into the marketplace, driving a multibillion dollar valuation and delivering drugs to patients